OVERVIEW

@MondayNight inflammatory bowel disease (IBD) LIVE: Identifying the Factors That Impact Success in Your Practice is organized by CME Outfitters, LLC.

Dates:
Premiere Date: Monday, October 26, 2020
Credit Expiration Date: Tuesday, October 26, 2021

Accreditation:
CME Credit (Physicians):
CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs).

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Note to PAs:
PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME or a recognized state medical society.

Statement of Need:
@MondayNightIBD brings social media and clinical practice influencers in gastroenterology together in a weekly online conversation that has become an international platform, moving the field of gastroenterology forward. It crowdsources the knowledge and experience of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients to meet the many challenges of IBD.

In this live webcast, CME Outfitters and @MondayNightIBD come together to bring you a panel of experts who will tailor a series of patient cases. These cases will focus on the application of cutting-edge data for novel therapies, identifying appropriate treatment strategies for special populations such as young patients and racial/ethnic minorities, and developing patient communication strategies, with the aim of achieving optimal patient outcomes.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Apply efficacy, safety, and comparative effectiveness data for existing and emerging therapies to optimize therapy selection for patients with IBD.
• Identify appropriate treatment strategies for special populations with IBD such as young patients and racial/ethnic minorities.
• Develop strategies such as disease monitoring, shared decision-making (SDM), and patient education in order to achieve optimal patient outcomes.